Status:
UNKNOWN
Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum TWEAK Level in Psoriasis
Lead Sponsor:
Aswan University Hospital
Conditions:
Psoriasis
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
The aim of the study is to evaluate the effect of NB-UVB versus MTX on serum TWEAK level in psoriatic patients.
Eligibility Criteria
Inclusion
- Patients with moderate to severe plaque psoriasis of any age and gender.
Exclusion
- History of psoriasis treatment with systemic and biological agents prior to the study for at least 3 months.
- Pregnancy and lactation.
- Infections
- Patients with chronic diseases: hepatic disorders, hematologic disease, chronic renal failure or cancer
Key Trial Info
Start Date :
December 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04811911
Start Date
December 13 2020
End Date
December 15 2021
Last Update
March 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aswan University - Faculty of Medicine
Aswān, Aswan Governorate, Egypt, 81528